The efficacy and safety of Saccharomyces boulardii in addition to antofloxacin-based bismuth quadruple therapy for Helicobacter pylori eradication: a single-center, prospective randomized-control study

BACKGROUND: We previously reported that antofloxacin-based bismuth quadruple therapy was safe and effective for Helicobacter pylori (H. pylori) eradication. It is not clear whether the addition of Saccharomyces boulardii (S. boulardii) to antofloxacin-based quadruple therapy can improve the eradicat...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Xiao-Jian, Wang, Xiao-Ling, Sun, Dong-Jie, Huang, Xiao-Yan, Liu, Gang, Li, Da-Zhou, Lin, Hai-Lan, Zeng, Xiang-Peng, Li, Dong-Liang, Wang, Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Helicobacter pylori Infection — pathogenesis, management and prevention
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893347/
https://www.ncbi.nlm.nih.gov/pubmed/36742013
http://dx.doi.org/10.1177/17562848221147763

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893347/
https://www.ncbi.nlm.nih.gov/pubmed/36742013
http://dx.doi.org/10.1177/17562848221147763

Ejemplares similares